David Wheadon

David Wheadon

Directeur/Membre du Conseil chez VAXART, INC.

Fortune : 2 M $ au 31/05/2026

69 ans
Health Technology
Commercial Services
Consumer Services

Profil

David E.
Wheadon
is Independent Chairman at Indivior Pharmaceuticals, Inc. since 2026.
Chairman at Indivior Ltd. since 2025.
Director at PSKW LLC since 2020.
Independent Non-Executive Director at Sotera Health Co. since 2021.
Independent Director at Vaxart, Inc. since 2021.
Independent Director at Seaport Therapeutics, Inc. since 2024.
Member of the American Psychiatric Association and the American Academy of Pharmaceutical Physicians.
Trustee at The Mount Sinai Health System, Inc. Formerly Director at Assertio Therapeutics, Inc. from 2019 to 2020.
Independent Director at ChemoCentryx, Inc. in 2022.
Director-Clinical Research at Smithkline Beecham Pharmaceuticals Ltd. from 1997 to 2000.
Director at Make-A-Wish Foundation of Illinois.
Director at Assertio Holdings, Inc. from 2019 to 2020.
Independent Director at Karuna Therapeutics, Inc. from 2020 to 2024.
Senior VP-Global Pharmaceutical Regulatory at Abbott Laboratories from 2005 to 2009.
Clinical Research Physician at Eli Lilly & Co. Senior Vice President-Global Regulatory Affairs at AstraZeneca PLC from 2014 to 2019.
Senior Vice President-US Regulatory Affairs at GSK Plc and GlaxoSmithKline Pharmaceuticals Ltd. from 2000 to 2005.
SVP-Global Regulatory Affairs & Patient Safety at AstraZeneca Pharmaceuticals LP from 2014 to 2019.
Executive Vice President-Research & Advocacy at JDRF International.
Senior VP-Scientific & Regulatory Affairs at Pharmaceutical Research & Manufacturers of America from 2009 to 2013.
Executive Vice President-Research & Advocacy at Juvenile Diabetes Research Foundation from 2013 to 2014.
Education includes undergraduate degree from Harvard College and doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/05/2026 74 912 ( 0,03% ) 1 M $ 31/05/2026
0,03%
13/05/2026 30 780 ( 0,03% ) 1 M $ 31/05/2026
26/05/2026 46 750 ( 0,02% ) 30 154 $ 31/05/2026
-.--%
01/05/2026 0 ( -.--% ) - $ 31/05/2026

Postes actifs de David Wheadon

SociétésPosteDébut
VAXART, INC. Directeur/Membre du Conseil 21/04/2021
SOTERA HEALTH COMPANY Directeur/Membre du Conseil 01/05/2021
Directeur/Membre du Conseil -
Président 28/01/2025
Directeur/Membre du Conseil 01/12/2020
Directeur/Membre du Conseil -
American Academy of Pharmaceutical Physicians
Corporate Officer/Principal -

Anciens postes connus de David Wheadon

SociétésPosteFin
KARA THER Directeur/Membre du Conseil 18/03/2024
CHEMOCENTRYX, INC. Directeur/Membre du Conseil 20/10/2022
░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Wheadon

Formation de David Wheadon

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

67

Relations au 1er degré

24

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées24

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

American Academy of Pharmaceutical Physicians

Smithkline Beecham Pharmaceuticals Ltd.

Technology Services

Health Technology

Make-A-Wish Foundation of Illinois

Consumer Services

Consumer Services

Health Services

Commercial Services

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Wheadon
- 40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT